Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1974 1
1975 1
1976 1
1979 11
1980 1
1981 1
1987 1
1989 1
1991 1
1992 1
1993 5
1994 3
1995 4
1996 5
1997 1
1999 3
2000 4
2001 4
2002 7
2003 3
2004 5
2005 7
2006 11
2007 6
2008 12
2009 14
2010 13
2011 13
2012 14
2013 12
2014 21
2015 18
2016 19
2017 10
2018 11
2019 10
2020 14
2021 18
2022 13
2023 5
2024 2
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

292 results

Results by year

Filters applied: . Clear all
Page 1
Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema.
Diabetic Retinopathy Clinical Research Network; Wells JA, Glassman AR, Ayala AR, Jampol LM, Aiello LP, Antoszyk AN, Arnold-Bush B, Baker CW, Bressler NM, Browning DJ, Elman MJ, Ferris FL, Friedman SM, Melia M, Pieramici DJ, Sun JK, Beck RW. Diabetic Retinopathy Clinical Research Network, et al. N Engl J Med. 2015 Mar 26;372(13):1193-203. doi: 10.1056/NEJMoa1414264. Epub 2015 Feb 18. N Engl J Med. 2015. PMID: 25692915 Free PMC article. Clinical Trial.
Nystagmus.
Neely DE, Sprunger DT. Neely DE, et al. Curr Opin Ophthalmol. 1999 Oct;10(5):320-6. doi: 10.1097/00055735-199910000-00007. Curr Opin Ophthalmol. 1999. PMID: 10621545 Review.
Efficacy and Tolerability of Evolocumab vs Ezetimibe in Patients With Muscle-Related Statin Intolerance: The GAUSS-3 Randomized Clinical Trial.
Nissen SE, Stroes E, Dent-Acosta RE, Rosenson RS, Lehman SJ, Sattar N, Preiss D, Bruckert E, Ceška R, Lepor N, Ballantyne CM, Gouni-Berthold I, Elliott M, Brennan DM, Wasserman SM, Somaratne R, Scott R, Stein EA; GAUSS-3 Investigators. Nissen SE, et al. JAMA. 2016 Apr 19;315(15):1580-90. doi: 10.1001/jama.2016.3608. JAMA. 2016. PMID: 27039291 Clinical Trial.
Reply.
Zarubina AV, Neely DC, Clark ME, Huisingh CE, Samuels BC, Zhang Y, McGwin G Jr, Owsley C, Curcio CA. Zarubina AV, et al. Among authors: neely dc. Ophthalmology. 2017 Feb;124(2):e20-e21. doi: 10.1016/j.ophtha.2016.05.013. Ophthalmology. 2017. PMID: 28126088 Free PMC article. No abstract available.
Phenotype standardization for statin-induced myotoxicity.
Alfirevic A, Neely D, Armitage J, Chinoy H, Cooper RG, Laaksonen R, Carr DF, Bloch KM, Fahy J, Hanson A, Yue QY, Wadelius M, Maitland-van Der Zee AH, Voora D, Psaty BM, Palmer CN, Pirmohamed M. Alfirevic A, et al. Among authors: neely d. Clin Pharmacol Ther. 2014 Oct;96(4):470-6. doi: 10.1038/clpt.2014.121. Epub 2014 Jun 4. Clin Pharmacol Ther. 2014. PMID: 24897241 Free PMC article.
292 results